SGD Pharma has broadened its offering with additional moulded and tubular glass containers alongside a third-party processing service for pharmaceutical manufacturers.
The company has introduced MySterinity Nasal, an addition to its Sterinity line targeted at the nasal administration sector.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Developed for biologic formulations subject to stringent microbiological criteria, the Type I U-Save vials are intended for vaccines, central nervous system treatments, and systemic therapies.
The units can be supplied in pre-washed, depyrogenated, or sterilised states to support quality compliance, safety standards, and overall total cost of ownership.
Additionally, the supplier has released ready-to-use (RTU) tubular vials for sensitive injectable medicines.
Supplied washed, depyrogenated, and sterilised for aseptic fill-finish workflows, the Type I containers are manufactured within an ISO 5 environment at the company’s facility in Felino, Italy, following its acquisition of Alphial.
The line provides clients with a single-vendor option for pre-treated tubular formats.
Alongside the container lines, SGD Pharma has launched MySealian, a Good Manufacturing Practice-compliant subcontracting service.
The operation permits pharmaceutical firms, original equipment manufacturers, and third-party glassmakers to apply the Sealian internal barrier treatment to their existing moulded containers without direct machinery expenditure.
The hydrophobic surface layer stops viscous liquids from adhering to inner container walls, assisting visual inspection, decreasing product residue, and safeguarding delicate formulations.
SGD Pharma CEO Olivier Rousseau said: “One year after the acquisition of Alphial, SGD Pharma is well positioned to address the evolving challenges of the pharmaceutical industry, offering innovative products and solutions across both moulded and tubular glass primary packaging. We are particularly proud that these innovations are developed within a comprehensive ESG framework, ensuring that sustainability considerations are embedded from the very outset of every project.”
